Estimation of an in vivo fitness landscape experienced by HIV-1 under drug selective pressure useful for prediction of drug resistance evolution during treatment
暂无分享,去创建一个
Yves Moreau | Anne-Mieke Vandamme | Ricardo Camacho | Andrew Rambaut | Kristel Van Laethem | Philippe Lemey | Koen Deforche | P. Lemey | Y. Moreau | A. Rambaut | A. Vandamme | K. Deforche | R. Camacho | K. Laethem
[1] Rafael Sanjuán,et al. The contribution of epistasis to the architecture of fitness in an RNA virus. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[2] D. Brutlag,et al. Discovering structural correlations in α‐helices , 1994 .
[3] Matthew J. Gonzales,et al. Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database: an expanded data model integrating natural language text and sequence analysis programs , 2001, Nucleic Acids Res..
[4] Amalio Telenti,et al. Update of the drug resistance mutations in HIV-1: Fall 2005. , 2005, Topics in HIV medicine : a publication of the International AIDS Society, USA.
[5] Yves Moreau,et al. Estimating the Relative Contribution of dNTP Pool Imbalance and APOBEC3G/3F Editing to HIV Evolution In Vivo , 2007, J. Comput. Biol..
[6] J. Coffin,et al. Linkage disequilibrium test implies a large effective population number for HIV in vivo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[7] Henry Tirri,et al. B-Course: A Web-Based Tool for Bayesian and Causal Data Analysis , 2002, Int. J. Artif. Intell. Tools.
[8] W. Ewens. Mathematical Population Genetics , 1980 .
[9] JD Lundgren,et al. Updated European Recommendations for the Clinical Use of HIV Drug Resistance Testing , 2004, Antiviral therapy.
[10] Thomas Lengauer,et al. Learning multiple evolutionary pathways from cross-sectional data , 2004, J. Comput. Biol..
[11] A. Vandamme,et al. Interpreting resistance data for HIV-1 therapy management--know the limitations. , 2006, AIDS reviews.
[12] T. Leitner,et al. Stochastic processes strongly influence HIV-1 evolution during suboptimal protease-inhibitor therapy. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[13] Yves Moreau,et al. Analysis of HIV-1 pol sequences using Bayesian Networks: implications for drug resistance , 2006, Bioinform..
[14] Tulio de Oliveira,et al. An automated genotyping system for analysis of HIV-1 and other microbial sequences , 2005, Bioinform..
[15] Robert C. Elston,et al. Mathematical population genetics, Biomathematics. , 1981 .
[16] L. M. Mansky,et al. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase , 1995, Journal of virology.
[17] Nicholas Eriksson,et al. Evolution on distributive lattices. , 2005, Journal of theoretical biology.
[18] Thomas Lengauer,et al. Estimating HIV evolutionary pathways and the genetic barrier to drug resistance. , 2005, The Journal of infectious diseases.
[19] Thomas Lengauer,et al. Data and text mining Computational methods for the design of effective therapies against drug resistant HIV strains , 2005 .
[20] L B Sheiner,et al. Kinetics of pharmacologic response. , 1982, Pharmacology & therapeutics.
[21] References , 1971 .
[22] K. Crandall,et al. The causes and consequences of HIV evolution , 2004, Nature Reviews Genetics.
[23] D. Richman,et al. 2022 update of the drug resistance mutations in HIV-1. , 2022, Topics in antiviral medicine.
[24] E. De Clercq,et al. Managing resistance to anti-HIV drugs: an important consideration for effective disease management. , 1999, Drugs.
[25] A. Vandamme,et al. A Genotypic Drug Resistance Interpretation Algorithm that Significantly Predicts Therapy Response in HIV-1-Infected Patients , 2001, Antiviral therapy.
[26] Michael P. Cummings,et al. PAUP* [Phylogenetic Analysis Using Parsimony (and Other Methods)] , 2004 .
[27] Robert W. Shafer,et al. Genotypic Testing for Human Immunodeficiency Virus Type 1 Drug Resistance , 2002, Clinical Microbiology Reviews.
[28] Lynn Morris,et al. Impact of HIV-1 Subtype and Antiretroviral Therapy on Protease and Reverse Transcriptase Genotype: Results of a Global Collaboration , 2005, PLoS medicine.
[29] M. P. Cummings,et al. PAUP* Phylogenetic analysis using parsimony (*and other methods) Version 4 , 2000 .